Correlation Between INmune Bio and Axsome Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both INmune Bio and Axsome Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining INmune Bio and Axsome Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between INmune Bio and Axsome Therapeutics, you can compare the effects of market volatilities on INmune Bio and Axsome Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in INmune Bio with a short position of Axsome Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of INmune Bio and Axsome Therapeutics.

Diversification Opportunities for INmune Bio and Axsome Therapeutics

-0.18
  Correlation Coefficient

Good diversification

The 3 months correlation between INmune and Axsome is -0.18. Overlapping area represents the amount of risk that can be diversified away by holding INmune Bio and Axsome Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Axsome Therapeutics and INmune Bio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on INmune Bio are associated (or correlated) with Axsome Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Axsome Therapeutics has no effect on the direction of INmune Bio i.e., INmune Bio and Axsome Therapeutics go up and down completely randomly.

Pair Corralation between INmune Bio and Axsome Therapeutics

Given the investment horizon of 90 days INmune Bio is expected to generate 1.9 times less return on investment than Axsome Therapeutics. In addition to that, INmune Bio is 1.73 times more volatile than Axsome Therapeutics. It trades about 0.01 of its total potential returns per unit of risk. Axsome Therapeutics is currently generating about 0.03 per unit of volatility. If you would invest  7,729  in Axsome Therapeutics on August 26, 2024 and sell it today you would earn a total of  2,139  from holding Axsome Therapeutics or generate 27.67% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

INmune Bio  vs.  Axsome Therapeutics

 Performance 
       Timeline  
INmune Bio 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days INmune Bio has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's primary indicators remain somewhat strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.
Axsome Therapeutics 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Axsome Therapeutics are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of very weak basic indicators, Axsome Therapeutics may actually be approaching a critical reversion point that can send shares even higher in December 2024.

INmune Bio and Axsome Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with INmune Bio and Axsome Therapeutics

The main advantage of trading using opposite INmune Bio and Axsome Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if INmune Bio position performs unexpectedly, Axsome Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Axsome Therapeutics will offset losses from the drop in Axsome Therapeutics' long position.
The idea behind INmune Bio and Axsome Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.

Other Complementary Tools

Transaction History
View history of all your transactions and understand their impact on performance
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Stocks Directory
Find actively traded stocks across global markets
Bonds Directory
Find actively traded corporate debentures issued by US companies
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets